mProX™ Human NRP1 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
There are currently no Customer reviews or questions for mProX™ Human NRP1 Stable Cell Line (S01YF-1023-PY281). Click the button above to contact us or submit your feedback about this product.
Casey Garcia (Verified Customer)
Patrick Liam (Creative Biolabs Scientific Support)
Peyton Brown (Verified Customer)
Patrick Liam (Creative Biolabs Scientific Support)
Published Data
Fig.1 An elevation in β1 integrin expression is observed in cells when NRP1 undergoes knockdown.
The expression level of β1 integrin is elevated and its downstream signals are activated by the knockdown of neuropilin 1 (NRP1). Transfection was performed on SK-N-AS cells with either NRP1 siRNA or control siRNA. After 48 hours post-transfection, cell lysates and total RNA were prepared and subjected to analysis through immunoblotting.
Ref: Ishizuka, Yoshiaki, et al. "NRP1 knockdown promotes the migration and invasion of human neuroblastoma-derived SK‑N‑AS cells via the activation of β1 integrin expression." International Journal of Oncology 53.1 (2018): 159-166.
Pubmed: 29750423
DOI: 10.3892/ijo.2018.4397
Research Highlights
R Schnittman, Samuel. et al. "Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus." Open forum infectious diseases, 2023.
The largest association with coronary plaque in the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) proteomics analysis was found in the plasma vascular endothelial growth factor (VEGF) coreceptor neuropilin-1 (NRP-1). The relationship between NRP-1 and other proteins in people with human immunodeficiency virus (PWH) was explored within REPRIEVE, and further validated in a Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) case-cohort study. Within REPRIEVE, NRP-1 showed connections to proteins involved in angiogenesis, signal transduction, immunoregulation, and cell migration/adhesion. In the CNICS study, associations were found between NRP-1 and important host factors such as older age and male sex, as well as an increased risk of multiple cancers and a decreased risk of prostate cancer. These findings also suggest a strong connection between NRP-1 and mortality and type 2 myocardial infarction, indicating its role in a potentially significant immunoregulatory pathway related to multiple comorbidities in PWH.
R Schnittman, Samuel. et al. "Biological and Clinical Implications of the Vascular Endothelial Growth Factor Coreceptor Neuropilin-1 in Human Immunodeficiency Virus." Open forum infectious diseases, 2023.
Pubmed:
37869406
DOI:
10.1093/ofid/ofad467
Zhang, Xin. et al. "Comprehensive characterization of pathogenic synovial fluid extracellular vesicles from knee osteoarthritis." Clinical immunology (Orlando, Fla.), 2023.
The study observed Synovial fluid (SF) extracellular vesicles (EVs) and their role in osteoarthritis (OA). The surface markers, cell and tissue origins, and effectors of these EVs are yet to be fully understood. A total of 692 peptides were identified in SF EVs, and they were positively correlated with the severity of knee radiographic OA. The majority of these peptides (57.4%) were associated with the innate immune system. CSPG4, BGN, NRP1, and CD109 were identified as the major surface markers of pathogenic SF EVs. Further analysis showed that chondrocytes in damaged cartilage significantly expressed the genes for CSPG4 and CD109, while synovial immune cells expressed VISG4, MARCO, CD163, and NRP1. The presence of CSPG4+ EVs in SF was found to be associated with the severity of knee OA.
Zhang, Xin. et al. "Comprehensive characterization of pathogenic synovial fluid extracellular vesicles from knee osteoarthritis." Clinical immunology (Orlando, Fla.), 2023.
Pubmed:
37866785
DOI:
10.1016/j.clim.2023.109812